Found 305 with Last Name = 'gelin' and Initial = 'm' 
Affinity DataKi: 0.0600nMAssay Description:Inhibition of pig APN using L-leucine-p-nitroanilide as substrate measured every 10 mins for 2 hrs by spectriphotometric analysisMore data for this Ligand-Target Pair
Affinity DataKi: 0.200nMAssay Description:Inhibition of mouse APN using L-leucine-p-nitroanilide as substrate measured every 10 mins for 2 hrs by spectriphotometric analysisMore data for this Ligand-Target Pair
Affinity DataKi: 0.350nMAssay Description:Inhibition of human APN using L-leucine-p-nitroanilide as substrate measured every 10 mins for 2 hrs by spectriphotometric analysisMore data for this Ligand-Target Pair
Affinity DataKi: 7nMAssay Description:Inhibition of pig APN using L-leucine-p-nitroanilide as substrate measured every 10 mins for 2 hrs by spectriphotometric analysisMore data for this Ligand-Target Pair
Affinity DataKi: 10nMAssay Description:Inhibition of mouse APN using L-leucine-p-nitroanilide as substrate measured every 10 mins for 2 hrs by spectriphotometric analysisMore data for this Ligand-Target Pair
Affinity DataKi: 11nMAssay Description:Inhibition of human APN using L-leucine-p-nitroanilide as substrate measured every 10 mins for 2 hrs by spectriphotometric analysisMore data for this Ligand-Target Pair
Affinity DataKi: 1.00E+3nMAssay Description:Inhibition of pig APN using L-leucine-p-nitroanilide as substrate measured every 10 mins for 2 hrs by spectriphotometric analysisMore data for this Ligand-Target Pair
Affinity DataKi: 2.00E+3nMAssay Description:Inhibition of human APN using L-leucine-p-nitroanilide as substrate measured every 10 mins for 2 hrs by spectriphotometric analysisMore data for this Ligand-Target Pair
Affinity DataKi: 2.00E+3nMAssay Description:Inhibition of mouse APN using L-leucine-p-nitroanilide as substrate measured every 10 mins for 2 hrs by spectriphotometric analysisMore data for this Ligand-Target Pair
Affinity DataKi: 5.00E+3nMAssay Description:For inhibitor assays, IC50 was determined, in the presence of 1 mM NAD and 4 mM ATP (for LmNADK1) or 2 mM ATP (for SaNADK). Dixon plots were used to ...More data for this Ligand-Target Pair
Affinity DataKi: 1.00E+4nMAssay Description:For inhibitor assays, IC50 was determined, in the presence of 1 mM NAD and 4 mM ATP (for LmNADK1) or 2 mM ATP (for SaNADK). Dixon plots were used to ...More data for this Ligand-Target Pair
Affinity DataKi: 1.50E+4nMAssay Description:For inhibitor assays, IC50 was determined, in the presence of 1 mM NAD and 4 mM ATP (for LmNADK1) or 2 mM ATP (for SaNADK). Dixon plots were used to ...More data for this Ligand-Target Pair
Affinity DataKi: 2.00E+4nMAssay Description:For inhibitor assays, IC50 was determined, in the presence of 1 mM NAD and 4 mM ATP (for LmNADK1) or 2 mM ATP (for SaNADK). Dixon plots were used to ...More data for this Ligand-Target Pair
Affinity DataKi: 2.00E+4nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 3.00E+4nMAssay Description:For inhibitor assays, IC50 was determined, in the presence of 1 mM NAD and 4 mM ATP (for LmNADK1) or 2 mM ATP (for SaNADK). Dixon plots were used to ...More data for this Ligand-Target Pair
Affinity DataKi: 5.00E+4nMAssay Description:For inhibitor assays, IC50 was determined, in the presence of 1 mM NAD and 4 mM ATP (for LmNADK1) or 2 mM ATP (for SaNADK). Dixon plots were used to ...More data for this Ligand-Target Pair
Affinity DataKi: 5.50E+4nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 6.50E+4nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 8.00E+4nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 8.00E+4nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 1.30E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 1.30E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 1.40E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 1.40E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 1.40E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 1.40E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 1.50E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 1.60E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 1.60E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 1.80E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 2.00E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 2.10E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 2.20E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 2.30E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 2.50E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 3.00E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 3.30E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 3.35E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 3.50E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 3.50E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 4.25E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 5.25E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataKi: 7.75E+5nMAssay Description:Inhibition of human NADK expressed in Escherichia coli BL21(DE3) assessed as reduction in NADP production using NAD as substrate by glucose-6-phospha...More data for this Ligand-Target Pair
Affinity DataIC50: 0.5nMAssay Description:Inhibition of N-terminal His-tagged human B-Raf kinase domain (448 to 723 residues) expressed in Escherichia coli BL21 (DE3) by Lanthascreen assayMore data for this Ligand-Target Pair
3D Structure (crystal)
Affinity DataIC50: 1.70nMAssay Description:Inhibition of N-terminal His-tagged human recombinant B-Raf V600E mutant (448 to 723 residues) expressed in Escherichia coli BL21 (DE3) by Lanthascre...More data for this Ligand-Target Pair
Affinity DataIC50: 1.70nMAssay Description:Inhibition of N-terminal His-tagged human recombinant B-Raf V600E mutant (448 to 723 residues) expressed in Escherichia coli BL21 (DE3) by Lanthascre...More data for this Ligand-Target Pair
Affinity DataIC50: 2nMAssay Description:Inhibition of N-terminal His-tagged human recombinant B-Raf V600E mutant (448 to 723 residues) expressed in Escherichia coli BL21 (DE3) by Lanthascre...More data for this Ligand-Target Pair
Affinity DataIC50: 2.10nMAssay Description:Inhibition of N-terminal His-tagged human recombinant B-Raf V600E mutant (448 to 723 residues) expressed in Escherichia coli BL21 (DE3) by Lanthascre...More data for this Ligand-Target Pair
Affinity DataIC50: 3.60nMAssay Description:Inhibition of N-terminal His-tagged human recombinant B-Raf V600E mutant (448 to 723 residues) expressed in Escherichia coli BL21 (DE3) by Lanthascre...More data for this Ligand-Target Pair
Affinity DataIC50: 4.40nMAssay Description:Inhibition of N-terminal His-tagged human recombinant B-Raf V600E mutant (448 to 723 residues) expressed in Escherichia coli BL21 (DE3) by Lanthascre...More data for this Ligand-Target Pair
